G1 Therapeutics - Ownership and Business Overview

Life ScienceCompany

G1 Therapeutics Ownership

Who owns G1 Therapeutics?

G1 Therapeutics is owned by Pharmacosmos A/S. It was acquired on August 7, 2024.

G1 Therapeutics Business Overview

Where is G1 Therapeutics headquartered?

G1 Therapeutics is headquartered in Research Triangle Park, North Carolina.

What is G1 Therapeutics’ revenue?

G1 Therapeutics disclosed revenue of 83M USD for 2023 and 51M USD for 2022.

What sector is G1 Therapeutics in?

G1 Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 151 acquisitions of life science companies in 2024, including 13 acquisitions by private equity firms, and 138 by strategics.

G1 Therapeutics

G1 Therapeutics, Inc.

700 Park Offices Drive Suite 200,
Research Triangle Park, North Carolina 27709
United States,
(919) 213-9835
www.g1therapeutics.com

G1 Therapeutics is a commercial-stage oncology biopharmaceutical company developing and delivering next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA (trilaciclib). G1 Therapeutics is based in Research Triangle Park, North Carolina.


 Subscribe to unlock this and 205,946
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.